This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Cisplatin

Read time: 1 mins
Marketing start date: 23 Nov 2024
...
 

Summary of product characteristics


Effective Time

20230901

Version

1

Spl Product Data Elements

Cisplatin CISPLATIN CISPLATIN CISPLATIN SODIUM CHLORIDE HYDROCHLORIC ACID WATER

Brand Name

Cisplatin

Generic Name

CISPLATIN

Product Ndc

65219-359

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Cisplatin Injection 50 mL Carton Panel 50mg/50 ml Rx Cisplatin Injection BP 1 mg/ml KEMOPLAT Single Dose Vial 50 ml PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Cisplatin Injection 50 mL Carton Panel

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.